219 related articles for article (PubMed ID: 37553793)
1. Microbes mediated immunogenic cell death in cancer immunotherapy.
Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL
Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793
[TBL] [Abstract][Full Text] [Related]
2. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
[TBL] [Abstract][Full Text] [Related]
3. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system.
Calvillo-Rodríguez KM; Lorenzo-Anota HY; Rodríguez-Padilla C; Martínez-Torres AC; Scott-Algara D
Front Immunol; 2023; 14():1294434. PubMed ID: 38077402
[TBL] [Abstract][Full Text] [Related]
5. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
Yu S; Xiao H; Ma L; Zhang J; Zhang J
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic Cell Death Role in Urothelial Cancer Therapy.
Yadollahvandmiandoab R; Jalalizadeh M; Buosi K; Garcia-Perdomo HA; Reis LO
Curr Oncol; 2022 Sep; 29(9):6700-6713. PubMed ID: 36135095
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy.
Palanivelu L; Liu CH; Lin LT
Front Immunol; 2022; 13():1038226. PubMed ID: 36755812
[TBL] [Abstract][Full Text] [Related]
8. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
[TBL] [Abstract][Full Text] [Related]
9. Trial watch: chemotherapy-induced immunogenic cell death in oncology.
Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD
Oncoimmunology; 2023; 12(1):2219591. PubMed ID: 37284695
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic cell death in cancer therapy: Present and emerging inducers.
Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
[TBL] [Abstract][Full Text] [Related]
11. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
12. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y
ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549
[TBL] [Abstract][Full Text] [Related]
13. Polymeric Nanosystems for Immunogenic Cell Death-Based Cancer Immunotherapy.
Fu L; Zhou X; He C
Macromol Biosci; 2021 Jul; 21(7):e2100075. PubMed ID: 33885225
[TBL] [Abstract][Full Text] [Related]
14. [Immunogenic cell death in hematological malignancies].
Matsushita M
Rinsho Ketsueki; 2021; 62(7):709-716. PubMed ID: 34349052
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
Wang J; Ma J; Xie F; Miao F; Lv L; Huang Y; Zhang X; Yu J; Tai Z; Zhu Q; Bao L
Front Immunol; 2024; 15():1389173. PubMed ID: 38745666
[TBL] [Abstract][Full Text] [Related]
16. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future.
Sen S; Won M; Levine MS; Noh Y; Sedgwick AC; Kim JS; Sessler JL; Arambula JF
Chem Soc Rev; 2022 Feb; 51(4):1212-1233. PubMed ID: 35099487
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
18. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
Aria H; Rezaei M
Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
[TBL] [Abstract][Full Text] [Related]
20. Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers.
Shi F; Huang X; Hong Z; Lu N; Huang X; Liu L; Liang T; Bai X
Cancer Lett; 2023 May; 562():216167. PubMed ID: 37031916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
